Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Envarsus 1 mg prolonged-release tablets

Active Ingredient:
tacrolimus monohydrate
Company:  
Chiesi Limited See contact details
ATC code: 
L04AD02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Safety Alert
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Envarsus – prolonged-release tacrolimus tablets

{healthcare_pro_orange} For Healthcare Professionals
Educational materials for the healthcare professional (doctor or pharmacist) Please read the full Summary of Product Characteristics before prescribing Envarsus
{pdf_link}

Envarsus Patient Card

{healthcare_pro_orange} For Healthcare Professionals
Envarsus Prolonged-release tacrolimus tablets Patient Card

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Chiesi Limited
Company image
Address
Chiesi Limited, 333 Styal Road, Manchester, M22 5LG
Telephone
+44 (0) 161 488 5555
Telephone
0800 009 2329
Medical Information e-mail
[email protected]
WWW
http://www.chiesi.uk.com
Product Quality Complaints
[email protected]
Stock Availability
[email protected]
Stock Availability
https://qrco.de/bg07dl
Drug Safety e-mail
[email protected]
Medical Information Direct Line
+44 (0)1748 827 271
Medical Information Website
https://www.chiesimedical.co.uk